Zhe Zheng

Zhe Zheng

Auto-generated profile, based on publicly available information

Zhe Zheng

Department of Epidemiology of Microbial Diseases and the Public Health Modeling Unit, Yale School of Public Health

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
ZZZhe Zheng
Zhe Zheng
VPVirginia E. Pitzer
Virginia E. Pitzer
ESEugene D. Shapiro
Eugene D. Shapiro
LBLouis J. Bont
Louis J. Bont
DWDaniel M. Weinberger
Daniel M. Weinberger
Respiratory syncytial virus (RSV) infection is a leading cause of acute respiratory hospitalizations in infants, young children, and older people.1-3 Individuals develop only partial immunity following RSV infections, and this incomplete immunity permits reinfections throughout life.4 Although most infants are born with protective immunity against RSV infections due to antibodies from the mother that are acquired transplacentally, this protection wanes quickly.5-7

25 October 2022 in Pneumonia
Verified
Journal Article
Open access
PDF file
ZZZhe Zheng
Zhe Zheng
JWJoshua L. Warren
Joshua L. Warren
ESEugene D. Shapiro
Eugene D. Shapiro
VPVirginia E. Pitzer
Virginia E. Pitzer
DWDaniel M. Weinberger
Daniel M. Weinberger
Background: Surveillance for respiratory syncytial virus (RSV) likely captures just a fraction of the burden of disease. Understanding the burden of hospitalizations and disparities between populations can help to inform upcoming RSV vaccine programs and to improve surveillance. Methods: We obtained monthly age-, ZIP code- and cause-specific hospitalizations in New York, New Jersey, and Washington from the US State Inpatient Databases (2005–2014). We estimated the incidence of respiratory hospitalizations attributable to RSV by age and by socioeconomic status using regression models. We compared the estimated incidence and the recorded incidence (based on ICD9-CM) of RSV hospitalizations to estimate the under-recorded ratio in different subpopulations. Results: The estimated annual incidence of respiratory hospitalizations due to RSV was highest among infants < 1 year of age with low socioeconomic status (2800, 95% CrI [2600, 2900] per 100,000 person-years). We also estimated a considerable incidence in older adults (≥ 65 years of age), ranging from 130 to 960 per 100,000 person-years across different socioeconomic strata. The incidence of hospitalization recorded as being due to RSV represented a significant undercount, particularly in adults. Less than 5% of the estimated RSV hospitalizations were captured for those ≥ 65 years of age. Conclusions: RSV causes a considerable burden of hospitalization in young children and in older adults in the US, with variation by socioeconomic group. Recorded diagnoses substantially underestimate the incidence of hospitalization due to RSV in older adults.

25 June 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
ZZZhe Zheng
Zhe Zheng
VPVirginia E. Pitzer
Virginia E. Pitzer
JWJoshua Warren
Joshua Warren
DWDaniel M. Weinberger
Daniel M. Weinberger
RSV epidemic dynamics are influenced by local community characteristics and spatial spread.

25 June 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
DTDeus Thindwa
Deus Thindwa
KLKe Li
Ke Li
DCDominic Cooper-Wootton
Dominic Cooper-Wootton
ZZZhe Zheng
Zhe Zheng
VPVirginia E Pitzer
Virginia E Pitzer
DWDaniel M Weinberger
Daniel M Weinberger
Background: Annual epidemics of respiratory syncytial virus (RSV) had consistent timing and intensity between seasons prior to the SARS-CoV-2 pandemic (COVID-19). However, starting in April 2020, RSV seasonal activity declined due to COVID-19 non-pharmaceutical interventions (NPIs) before re-emerging after relaxation of NPIs. We described the unusual patterns of RSV epidemics that occurred in multiple subsequent waves following COVID-19 in different countries and explored factors associated with these patterns. Methods: Weekly cases of RSV from twenty-eight countries were obtained from the World Health Organisation and combined with data on country-level characteristics and the stringency of the COVID-19 response. Dynamic time warping and regression were used to cluster time series patterns and describe epidemic characteristics before and after COVID-19 pandemic, and identify related factors. Results: While the first wave of RSV epidemics following pandemic suppression exhibited unusual patterns, the second and third waves more closely resembled typical RSV patterns in many countries. Post-pandemic RSV patterns differed in their intensity and/or timing, with several broad patterns across the countries. The onset and peak timings of the first and second waves of RSV epidemics following COVID-19 suppression were earlier in the Southern than Northern Hemisphere. The second wave of RSV epidemics was also earlier with higher population density, and delayed if the intensity of the first wave was higher. More stringent NPIs were associated with lower RSV growth rate and intensity and a shorter gap between the first and second waves. Conclusion: Patterns of RSV activity have largely returned to normal following successive waves in the post-pandemic era. Onset and peak timings of future epidemics following disruption of normal RSV dynamics need close monitoring to inform the delivery of preventive and control measures.

27 October 2022 in npj Vaccines
Verified
Journal Article
Open access
PDF file
ZZZhe Zheng
Zhe Zheng
DWDaniel M. Weinberger
Daniel M. Weinberger
VPVirginia E. Pitzer
Virginia E. Pitzer
Several vaccines and extended half-life monoclonal antibodies (mAbs) against respiratory syncytial virus (RSV) have shown promise in clinical trials. We used age-structured transmission models to predict the possible impact of various RSV prevention strategies including maternal immunization, live-attenuated vaccines, and long-lasting mAbs. Our results suggest that maternal immunization and long-lasting mAbs are likely to be highly effective in preventing RSV hospitalizations in infants under 6 months of age, averting more than half of RSV hospitalizations in neonates. Live-attenuated vaccines could reduce RSV hospitalizations in vaccinated age groups and are also predicted to have a modest effect in unvaccinated age groups because of disruptions to transmission. Compared to year-round vaccination, a seasonal vaccination program at the country level provides at most a minor advantage regarding efficiency. Our findings highlight the substantial public health impact that upcoming RSV prevention strategies may provide.

8 February 2022 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
ZZZhe Zheng
Zhe Zheng
JWJoshua Warren
Joshua Warren
IAIris Artin
Iris Artin
VPVirginia E. Pitzer
Virginia E. Pitzer
DWDaniel M. Weinberger
Daniel M. Weinberger
We used a validated proxy of respiratory syncytial virus (RSV) activity in the United States (Google search data) to evaluate the onsets of RSV epidemics in 2021 and 2016–2019. Despite the unusual out‐of‐season summer timing, the relative timing of RSV epidemics between states in 2021 shared a similar spatial pattern with typical winter RSV seasons. Our results suggest that the onset of RSV epidemics in Florida can serve as a baseline to adjust the initiation of prophylaxis administration and clinical trials in other states regardless of the seasonality of RSV epidemics.